Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

BUY
$193.75 - $232.55 $18,406 - $22,092
95 Added 5.35%
1,870 $434,000
Q4 2022

Feb 10, 2023

SELL
$187.24 - $242.74 $134,812 - $174,772
-720 Reduced 28.86%
1,775 $358,000
Q3 2022

Oct 13, 2022

SELL
$177.23 - $227.44 $8,861 - $11,372
-50 Reduced 1.96%
2,495 $514,000
Q2 2022

Jul 18, 2022

SELL
$181.58 - $368.0 $22,697 - $46,000
-125 Reduced 4.68%
2,545 $515,000
Q1 2022

Apr 28, 2022

SELL
$303.87 - $423.8 $125,194 - $174,605
-412 Reduced 13.37%
2,670 $933,000
Q4 2021

Jan 20, 2022

BUY
$347.28 - $421.83 $10,071 - $12,233
29 Added 0.95%
3,082 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $25,147 - $32,540
62 Added 2.07%
3,053 $1.24 Million
Q2 2021

Aug 03, 2021

BUY
$372.84 - $481.5 $43,249 - $55,854
116 Added 4.03%
2,991 $1.42 Million
Q1 2021

Apr 23, 2021

BUY
$361.28 - $504.76 $28,902 - $40,380
80 Added 2.86%
2,875 $1.1 Million
Q4 2020

Feb 02, 2021

BUY
$292.7 - $370.96 $594,181 - $753,048
2,030 Added 265.36%
2,795 $1.03 Million
Q2 2020

Jul 20, 2020

SELL
$256.46 - $373.01 $10,258 - $14,920
-40 Reduced 4.97%
765 $283,000
Q1 2020

Apr 16, 2020

SELL
$209.2 - $335.53 $60,040 - $96,297
-287 Reduced 26.28%
805 $220,000
Q4 2019

Jan 14, 2020

SELL
$288.29 - $335.49 $28,829 - $33,549
-100 Reduced 8.39%
1,092 $362,000
Q2 2019

Jul 11, 2019

SELL
$300.59 - $368.15 $6,913 - $8,467
-23 Reduced 1.89%
1,192 $439,000
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $13,628 - $16,059
-50 Reduced 3.95%
1,215 $377,000
Q4 2018

Feb 12, 2019

BUY
$272.46 - $366.54 $108,983 - $146,616
400 Added 46.24%
1,265 $379,000
Q3 2017

Dec 13, 2017

SELL
$172.3 - $213.93 $105,964 - $131,566
-615 Reduced 41.55%
865 $172,000
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $105,964 - $131,566
615 Added 71.1%
1,480 $172,000
Q2 2017

Aug 14, 2017

BUY
N/A
865
865 $168,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Patten Group, Inc. Portfolio

Follow Patten Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.